Companion Diagnostics Market Size, Share & Industry Analysis, By Technology (Polymerase Chain Reaction, Immunohistochemistry, In-situ Hybridization, Next Generation Gene Sequencing, and Others), By Indication (Cancer, Neurological Diseases, Infectious Diseases, and Others), By End-user (Pharmaceutical & Biopharmaceutical Companies, Reference Laboratories, Contract Research Organizations, and Others), and Regional Forecast, 2024-2032

ATTRIBUTE

DETAILS

Study Periods

2019-2032

Base Year

2023

Estimated Year 

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR 11.5% from 2024-2032

Unit

Value (USD billion)

Segmentation

By Technology

• Polymerase Chain Reaction
• Immunohistochemistry
• In-situ Hybridization
• Next Generation Gene Sequencing
• Others

By Indication

• Cancer
• Neurological Diseases
• Infectious Diseases
• Others

By End-user

• Pharmaceutical & Biopharmaceutical Companies
• Reference Laboratories
• Contract Research Organizations (CROs)

By Geography

• North America (By Technology, By Indication, By End-user, By Country)
  • U.S.
  • Canada
• Europe (By Technology, By Indication, By End-user, By Country/Sub-Region)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Technology, By Indication, By End-user, By Country/Sub-Region)
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Technology, By Indication, By End-user, By Country/Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Technology, By Indication, By End-user, By Country/Sub-Region)
  • GCC
  • South Africa
  • Rest of Middle East & Africa